Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report)’s stock price dropped 0.8% during mid-day trading on Wednesday . The company traded as low as C$2.51 and last traded at C$2.53. Approximately 74,200 shares were traded during trading, a decline of 48% from the average daily volume of 141,666 shares. The stock had previously closed at C$2.55.
Cardiol Therapeutics Stock Down 0.8 %
The stock has a market capitalization of C$176.80 million, a P/E ratio of -5.75 and a beta of 0.70. The company has a debt-to-equity ratio of 1.07, a current ratio of 2.39 and a quick ratio of 6.84. The stock has a 50 day moving average price of C$2.72 and a 200-day moving average price of C$2.84.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- How to Plot Fibonacci Price Inflection Levels
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Stock Average Calculator
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
